United Therapeutics Corporation EPS (Earnings per Share) 2008–2025
United Therapeutics Corporation reported $27.86 of earnings per share for fiscal 2025. That was 13.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +141.4%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $27.86 | +13.1% |
| FY 2024 | $24.64 | +24.4% |
| FY 2023 | $19.81 | +32.1% |
| FY 2022 | $15.00 | +49.1% |
| FY 2021 | $10.06 | -12.8% |
| FY 2020 | $11.54 | +582.8% |
| FY 2019 | $-2.39 | -117.8% |
| FY 2018 | $13.39 | +43.8% |
| FY 2017 | $9.31 | -39.0% |
| FY 2016 | $15.25 | +19.9% |
| FY 2015 | $12.72 | +102.5% |
| FY 2014 | $6.28 | +91.5% |
| FY 2013 | $3.28 | -42.6% |
| FY 2012 | $5.71 | +55.6% |
| FY 2011 | $3.67 | +106.2% |
| FY 2010 | $1.78 | +408.6% |
| FY 2009 | $0.35 | +229.6% |
| FY 2008 | $-0.27 | — |
Source: United Therapeutics Corporation SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open UTHR 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
United Therapeutics Corporation reported $27.86 of earnings per share for fiscal 2025. That was 13.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +141.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for United Therapeutics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeUnited Therapeutics Corporation — frequently asked questions
What is United Therapeutics Corporation's earnings per share?
United Therapeutics Corporation (UTHR) reported earnings per share of $27.86 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from United Therapeutics Corporation's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.